Employing sphingomyelin catabolism inhibitors, including the acidic SMase inhibitor (A‐SMase inhibitor, LCL521) and the neutral SMase inhibitor (N‐SMase inhibitor, GW4869), we successfully reinstated the tumour cell lysis capacity of intratumoral NK cells.3 Here, SMPD2 is linked to neoplasm.